Isum Pharma

• Effectiveness
• Accurate PH value
• Zero side-effect

Ledipasvir and sofosbuvir are antiviral medications that prevent hepatitis C virus (HCV) from multiplying in your body.

Ledipasvir and sofosbuvir is a combination medicine used to treat hepatitis C genotypes 1, 4, 5, or 6. This medicine is for use in adults and children who are at least 12 years old or who weigh at least 77 pounds (35 kilograms).

Ledipasvir and sofosbuvir is sometimes given in combination with another medicine called ribavirin.

You should not use ledipasvir and sofosbuvir if you are allergic to it, or if you are also taking sofosbuvir tablets .

To make sure ledipasvir and sofosbuvir is safe for you, tell your doctor if you have:

• a history of hepatitis B;

• liver problems other than hepatitis;

• a history of liver transplant;

• kidney disease (or if you are on dialysis);

• HIV or AIDS; or

• a heart rhythm problem for which you take a medicine called amiodarone (Cordarone, Pacerone).

You should not use ledipasvir and sofosbuvir with ribavirin if you have:

• severe kidney disease;

• a hemoglobin blood cell disorder such as sickle-cell anemia or thalassemia; or

• if you are pregnant, or if you are a man and your  partner is pregnant.

Ledipasvir and sofosbuvir is not expected to harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

Ledipasvir and sofosbuvir is sometimes used together with another medicine called ribavirin. Ribavirin can cause birth defects or death in an unborn baby.You may need to have a negative pregnancy test before taking ribavirin and every month during your treatment.

• If you are a woman, do not take ribavirin if you are pregnant. If you are a man, do not take ribavirin if your partner is pregnant. An unborn baby could also be harmed if a man fathers the child while he is taking ribavirin.

• Use at least 2 effective forms of birth control to prevent pregnancy while either partner is taking ribavirin. Keep using 2 forms of birth control for at least 6 months after treatment ends.

• Tell your doctor right away if a pregnancy occurs while either the mother or the father is taking ribavirin.

• It is generally used in the treatment of hepatitis C and HCV.

Sofosbuvir and velpatasvir are antiviral medications that prevent hepatitis C virus (HCV) from multiplying in your body.

Sofosbuvir and velpatasvir is a combination medicine used to treat chronic hepatitis C in adults with HCV genotype 1, 2, 3, 4, 5, or 6.

This medicine is given in combination with another antiviral medicine called ribavirin in people who also have advanced cirrhosis.

You should not use this medicine if you are allergic to sofosbuvir or velpatasvir.

To make sure this medicine is safe for you, tell your doctor if you have:

• a history of hepatitis B;

• kidney disease (or if you are on dialysis);

• liver problems other than hepatitis;

• HIV (human immunodeficiency virus); or

• if you have recently used a heart rhythm medicine called amiodarone (Cordarone, Pacerone).

It is not known whether sofosbuvir and velpatasvir will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

This medicine is sometimes used in combination with ribavirin. Ribavirin can cause birth defects or death in an unborn baby. You may need to have a negative pregnancy test before using these medications together, and every month during your treatment.

• If you are a woman, do not use sofosbuvir and velpatasvir with ribavirin if you are pregnant.

• If you are a man, do not use this drug combination if your partner is pregnant. An unborn baby could also be harmed if a man fathers the child while he is taking ribavirin.

• Use effective birth control to prevent pregnancy while either partner is using these medications together. Keep using this birth control for at least 6 months after treatment ends. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using sofosbuvir and velpatasvir with ribavirin.

We are providing Myhep All (Sofosbuvir and Velpatasvir Tablets). It is a combination of sofosbuvir and velpatasvir. This drug work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Sofosbuvir and Velpatasvir are used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin).

• Ledifos is to be taken by adults over 18 years of age only.
• Ledifos is to be taken orally with a full glass of water.
• The maximum recommended dosing frequency is once per day.
• To be taken at the same time every day (24 hour gap).
• Ledifos's length of treatment may vary for a period between 8 weeks to 24 weeks.
• Do not stop use and intake of other anti-viral medications alongside Ledifos unless instructed by your doctor.

Daclatasvir is an antiviral medicine that prevents hepatitis C virus (HCV) from multiplying in your body.

Daclatasvir is used in combination with other medications to treat chronic hepatitis C in adults.

Daclatasvir treats specific genotypes of hepatitis C, and only in certain people. Use only the medications prescribed for you. Do not share your medicine with other people.

Daclatasvir must be given in combination with other antiviral medications and should not be used alone. Daclatasvir is usually given with sofosbuvir, with or without ribavirin.

Daclatasvir is sometimes used in people who also have HIV. Daclatasvir is not a treatment for HIV or AIDS.

You should not use daclatasvir if you are allergic to it. If you take daclatasvir with sofosbuvir: There may be other reasons you should not take this combination treatment. Tell your doctor about all your medical conditions.

If you take daclatasvir with ribavirin: There may be other reasons you should not take this combination treatment. Tell your doctor about all your medical conditions.

Some medicines can interact with daclatasvir and should not be used at the same time. Your doctor may need to change your treatment plan if you use any of the following drugs:

• rifampin;

• St. John's wort; or

• seizure medicine--carbamazepine, phenytoin.

To make sure daclatasvir is safe for you, tell your doctor if you have ever had:

• hepatitis B;

• liver problems other than hepatitis C;

• heart disease;

• if you have recently used a heart rhythm medicine called amiodarone (Cordarone, Nexterone, Pacerone); or

• if you use a blood thinner ( Coumadin, Jantoven) and you have routine "INR" or prothrombin time tests.

Daclatasvir is sometimes used in combination with ribavirin. Ribavirin can cause birth defects or death in an unborn baby.

• If you are a woman, do not use ribavirin if you are pregnant. You may need to have a negative pregnancy test before taking ribavirin and every month during your treatment.

• If you are a man, do not use ribavirin if your partner is pregnant. An unborn baby could be harmed if you have with a pregnant woman while you are taking ribavirin.

While taking daclatasvir with ribavirin, use at least 2 effective forms of birth control to prevent pregnancy, whether you are a man or a woman. Ribavirin use by either parent may cause birth defects.

Keep using 2 forms of birth control for at least 6 months after your last dose of ribavirin. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using ribavirin.

It is not known whether daclatasvir passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

Daclatasvir is not approved for use by anyone younger than 18 years old.

Sofosbuvir and velpatasvir are antiviral medications that prevent hepatitis C virus (HCV) from multiplying in your body.

Sofosbuvir and velpatasvir is a combination medicine used to treat chronic hepatitis C in adults with HCV genotype 1, 2, 3, 4, 5, or 6.

This medicine is given in combination with another antiviral medicine called ribavirin in people who also have advanced cirrhosis.

You should not use this medicine if you are allergic to sofosbuvir or velpatasvir.

To make sure this medicine is safe for you, tell your doctor if you have:

• a history of hepatitis B;

• kidney disease (or if you are on dialysis);

• liver problems other than hepatitis;

• HIV (human immunodeficiency virus); or

• if you have recently used a heart rhythm medicine called amiodarone (Cordarone, Pacerone).

It is not known whether sofosbuvir and velpatasvir will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

This medicine is sometimes used in combination with ribavirin. Ribavirin can cause birth defects or death in an unborn baby. You may need to have a negative pregnancy test before using these medications together, and every month during your treatment.

• If you are a woman, do not use sofosbuvir and velpatasvir with ribavirin if you are pregnant.

• If you are a man, do not use this drug combination if your sexual partner is pregnant. An unborn baby could also be harmed if a man fathers the child while he is taking ribavirin.

• Use effective birth control to prevent pregnancy while either sexual partner is using these medications together. Keep using this birth control for at least 6 months after treatment ends. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using sofosbuvir and velpatasvir with ribavirin.

• Velpanat is a prescription drug and should be used under proper medical guidance and advice.

Sofosbuvir is an antiviral medication that prevents hepatitis C virus (HCV) from multiplying in your body.

Sofosbuvir is used in combination with other medications to treat hepatitis C in adults and children who are at least 12 years old or who weigh at least 77 pounds (35 kilograms).

Sofosbuvir is sometimes used in people who also have HIV, or people who have liver cancer and are going to have a liver transplant. Sofosbuvir is not a treatment for HIV or AIDS.

Sofosbuvir must be given in combination with other antiviral medications and should not be used alone. Sofosbuvir is usually given with ribavirin (, Rebetol, Ribasphere, RibaTab) with or without peginterferon alfa (, PegIntron).

Read the medication guide or patient instructions provided with each medication in your combination therapy. Do not change your doses or medication schedule without your doctor's advice.

Ribavirin can cause birth defects or death in an unborn baby. Do not use sofosbuvir with ribavirin if you are pregnant, or if you are a man and your female partner is pregnant. Use at least 2 effective forms of non-hormonal birth control while using these medicines together and for at least 6 months after treatment ends.

You should not use sofosbuvir if you are allergic to it.

To make sure sofosbuvir is safe for you, tell your doctor if you have ever had:

• hepatitis B;

• liver problems other than hepatitis, or if you have had a liver transplant;

• kidney disease (or if you are on dialysis);

• HIV (human immunodeficiency virus); or

• if you have recently used a heart rhythm medicine called amiodarone (Cordarone, Pacerone).

• Velasof is a prescription drug and should be used under proper medical guidance and advice.

Ledipasvir and sofosbuvir are antiviral medications that prevent hepatitis C virus (HCV) from multiplying in your body.

Ledipasvir and sofosbuvir is a combination medicine used to treat hepatitis C genotypes 1, 4, 5, or 6. This medicine is for use in adults and children who are at least 12 years old or who weigh at least 77 pounds (35 kilograms).

Ledipasvir and sofosbuvir is sometimes given in combination with another medicine called ribavirin.To make sure ledipasvir and sofosbuvir is safe for you, tell your doctor if you have:

• a history of hepatitis B;

• liver problems other than hepatitis;

• a history of liver transplant;

• kidney disease (or if you are on dialysis);

• HIV or AIDS; or

• a heart rhythm problem for which you take a medicine called amiodarone (Cordarone, Pacerone).

You should not use ledipasvir and sofosbuvir with ribavirin if you have:

• severe kidney disease;

• a hemoglobin blood cell disorder such as sickle-cell anemia or thalassemia; or

• if you are pregnant, or if you are a man and your  partner is pregnant.

Ledipasvir and sofosbuvir is not expected to harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

Ledipasvir and sofosbuvir is sometimes used together with another medicine called ribavirin. Ribavirin can cause birth defects or death in an unborn baby.You may need to have a negative pregnancy test before taking ribavirin and every month during your treatment.

• If you are a woman, do not take ribavirin if you are pregnant. If you are a man, do not take ribavirin if your partner is pregnant. An unborn baby could also be harmed if a man fathers the child while he is taking ribavirin.

• Use at least 2 effective forms of birth control to prevent pregnancy while either

• partner is taking ribavirin. Keep using 2 forms of birth control for at least 6 months after treatment ends.

• Tell your doctor right away if a pregnancy occurs while either the mother or the father is taking ribavirin.

It is not known whether ledipasvir and sofosbuvir passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

• Sofocure L is a prescription drug and should be used under proper medical guidance and advice.

Sofosbuvir and velpatasvir are antiviral medications that prevent hepatitis C virus (HCV) from multiplying in your body.

Sofosbuvir and velpatasvir is a combination medicine used to treat chronic hepatitis C in adults with HCV genotype 1, 2, 3, 4, 5, or 6.

This medicine is given in combination with another antiviral medicine called ribavirin in people who also have advanced cirrhosis.

You should not use this medicine if you are allergic to sofosbuvir or velpatasvir.

To make sure this medicine is safe for you, tell your doctor if you have:

• a history of hepatitis B;

• kidney disease (or if you are on dialysis);

• liver problems other than hepatitis;

• HIV (human immunodeficiency virus); or

• if you have recently used a heart rhythm medicine called amiodarone (Cordarone, Pacerone).

It is not known whether sofosbuvir and velpatasvir will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

This medicine is sometimes used in combination with ribavirin. Ribavirin can cause birth defects or death in an unborn baby. You may need to have a negative pregnancy test before using these medications together, and every month during your treatment.

• If you are a woman, do not use sofosbuvir and velpatasvir with ribavirin if you are pregnant.

• If you are a man, do not use this drug combination if your partner is pregnant. An unborn baby could also be harmed if a man fathers the child while he is taking ribavirin.

• Use effective birth control to prevent pregnancy while either partner is using these medications together. Keep using this birth control for at least 6 months after treatment ends. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using sofosbuvir and velpatasvir with ribavirin.

• Quick result
• Highly Reliable

• Ledipasvir + Sofosbuvir is a combination pill used for treatment of different types of Genotypes of Hepatitis C. A 12 week or 24 weeks treatment is prescribed based on the level of cirrhosis.
• Used in the treatment of Hepatitis.

• Quick result
• Highly Reliable
• Longer shelf life

In order to meet the various requirements of the clients, we are actively engaged in offering our clients a wide range of Buy Sofosvel Tablet online.

Product Details:

• Each Film Coated Tablet Contains Sofosbuvir INN 400 mg and Velpatasvir INN 100 mg

• Treating chronic hepatitis C virus (HCV) infection in certain patients.

• Nausea, Diarrhea, Headaches, Loss of appetite, Lower back or side pain, Insomnia, Fever.

Sofosbuvir and velpatasvir are antiviral medications that prevent hepatitis C virus (HCV) from multiplying in your body.

Sofosbuvir and velpatasvir is a combination medicine used to treat chronic hepatitis C in adults with HCV genotype 1, 2, 3, 4, 5, or 6.

This medicine is given in combination with another antiviral medicine called ribavirin in people who also have advanced cirrhosis.

You should not use this medicine if you are allergic to sofosbuvir or velpatasvir.

To make sure this medicine is safe for you, tell your doctor if you have:

• a history of hepatitis B;

• kidney disease (or if you are on dialysis);

• liver problems other than hepatitis;

• HIV (human immunodeficiency virus); or

• if you have recently used a heart rhythm medicine called amiodarone (Cordarone, Pacerone).

It is not known whether sofosbuvir and velpatasvir will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

This medicine is sometimes used in combination with ribavirin. Ribavirin can cause birth defects or death in an unborn baby. You may need to have a negative pregnancy test before using these medications together, and every month during your treatment.

• If you are a woman, do not use sofosbuvir and velpatasvir with ribavirin if you are pregnant.

• If you are a man, do not use this drug combination if your partner is pregnant. An unborn baby could also be harmed if a man fathers the child while he is taking ribavirin.

• Use effective birth control to prevent pregnancy while either partner is using these medications together. Keep using this birth control for at least 6 months after treatment ends. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using sofosbuvir and velpatasvir with ribavirin.

• Velasof is a prescription drug and should be used under proper medical guidance and advice.

• Accurate composition
• Highly effective

Daclatasvir is an antiviral medicine that prevents hepatitis C virus (HCV) from multiplying in your body.

Daclatasvir is used to treat genotype 3 chronic hepatitis C in adults without cirrhosis. This medicine is given together with another drug called sofosbuvir.

You should not use daclatasvir if you are allergic to it. If you take daclatasvir with sofosbuvir: There may be other reasons you should not take this combination treatment. Tell your doctor about all your medical conditions.

Some medicines can interact with daclatasvir and should not be used at the same time. Your doctor may need to change your treatment plan if you use any of the following drugs:

• rifampin;

• St. John's wort; or

• seizure medicine--carbamazepine, phenytoin.

To make sure daclatasvir is safe for you, tell your doctor if you have:

• a history of hepatitis B;

• liver problems other than hepatitis;

• heart disease;

• if you also use amiodarone (a heart rhythm medicine); or

• if you have received a liver transplant.

It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

It is not known whether daclatasvir passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

Daclatasvir is not approved for use by anyone younger than 18 years old.

With our in-depth knowledge and rich industry experience in this field, we are highly engaged in supplying Virso Tablet for our esteemed clients. Processed employing advanced technology and using premium quality chemical compounds, offered tablet should only be used under proper medical guidance and advice. In order to maintain the effectiveness, our quality examiners test this tablet on various parameters.

Indicated for adults with chronic hepatitis C virus (HCV) infection genotypes 1, 2, 3, 4, 5, and 6

1 tablet (400 mg sofosbuvir/ 100 mg velpatasvir) PO qDay

Treatment duration

• Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Sofosbuvir/velpatasvir for 12 weeks
• Patients with decompensated cirrhosis (Child-Pugh B or C): Sofosbuvir/velpatasvir plus weight-based ribavirin with food for 12 weeks
• The above regimens also apply to patients coinfected with HIV-1
• Weight-based ribavirin dose
  • <75 kg: 1000 mg/day PO divided BID
  • ≥75 kg: 1200 mg/day PO divided BID
  • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

Renal impairment

• Severe renal impairment (eGFR <30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

Hepatic impairment

• Mild, moderate, or severe (Child-Pugh A, B, or C): No dosage adjustment required

Test all patients for evidence of current or prior hepatitis B virus (HBV) infection before initiating treatment with HCV direct acting antivirals (DDAs)

Coinfected with HIV-1 without cirrhosis or with compensated cirrhosis: HCV outcomes (SVR12) were ≥92% for all genotypes